NEU 6.20% $15.24 neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-8

  1. 2,035 Posts.
    lightbulb Created with Sketch. 479
    Let's get this original post at top thumbed up so it hits the HC top five ^.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.